189 related articles for article (PubMed ID: 22387587)
1. Tolerogenic dendritic cells as a target for the therapy of immune thrombocytopenia.
Fu J; Zhang A; Ju X
Clin Appl Thromb Hemost; 2012 Sep; 18(5):469-75. PubMed ID: 22387587
[TBL] [Abstract][Full Text] [Related]
2. Tolerogenic dendritic cells generated with IL-10/TGFβ1 relieve immune thrombocytopenia in mice.
Zhang A; Fu J; Ning B; Li D; Sun N; Wei W; Wei J; Ju X
Thromb Res; 2013 Jul; 132(1):63-8. PubMed ID: 23602734
[TBL] [Abstract][Full Text] [Related]
3. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy.
Andersson PO; Wadenvik H
Expert Rev Mol Med; 2004 Nov; 6(24):1-17. PubMed ID: 15538954
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells of immune thrombocytopenic purpura (ITP) show increased capacity to present apoptotic platelets to T lymphocytes.
Catani L; Fagioli ME; Tazzari PL; Ricci F; Curti A; Rovito M; Preda P; Chirumbolo G; Amabile M; Lemoli RM; Tura S; Conte R; Baccarani M; Vianelli N
Exp Hematol; 2006 Jul; 34(7):879-87. PubMed ID: 16797415
[TBL] [Abstract][Full Text] [Related]
5. Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.
Zhou Z; Li X; Li J; Su C; Zhuang L; Luo S; Zhang L
J Clin Immunol; 2010 Nov; 30(6):814-22. PubMed ID: 20628793
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of immune thrombocytopenia.
Audia S; Mahévas M; Samson M; Godeau B; Bonnotte B
Autoimmun Rev; 2017 Jun; 16(6):620-632. PubMed ID: 28428120
[TBL] [Abstract][Full Text] [Related]
7. TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura.
Yu H; Liu Y; Han J; Yang Z; Sheng W; Dai H; Wang Y; Xia T; Hou M
Eur J Haematol; 2011 Jan; 86(1):67-74. PubMed ID: 21039888
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
Zhao Y; Zhang A; Du H; Guo S; Ning B; Yang S
Rheumatol Int; 2012 Apr; 32(4):837-44. PubMed ID: 21904923
[TBL] [Abstract][Full Text] [Related]
10. Some unsettled questions in childhood thrombocytopenia caused by immunologic platelet destruction (acute and chronic ITP).
Gaedicke G; Schulze H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):668-70. PubMed ID: 16933247
[TBL] [Abstract][Full Text] [Related]
11. Circulating dendritic cells subsets and CD4+Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome.
Ling Y; Cao X; Yu Z; Ruan C
Eur J Haematol; 2007 Oct; 79(4):310-6. PubMed ID: 17692100
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of chronic immune thrombocytopenic purpura.
Cines DB; McMillan R
Curr Opin Hematol; 2007 Sep; 14(5):511-4. PubMed ID: 17934360
[TBL] [Abstract][Full Text] [Related]
13. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis.
Gernsheimer T
Oncologist; 2009 Jan; 14(1):12-21. PubMed ID: 19144680
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia.
Wen R; Wang Y; Hong Y; Yang Z
Blood Coagul Fibrinolysis; 2020 Mar; 31(2):113-120. PubMed ID: 31977328
[TBL] [Abstract][Full Text] [Related]
15. Current therapies in primary immune thrombocytopenia.
Pels SG
Semin Thromb Hemost; 2011 Sep; 37(6):621-30. PubMed ID: 22102265
[TBL] [Abstract][Full Text] [Related]
16. Circulating plasmacytoid dendritic cells in patients with primary and Helicobacter pylori-associated immune thrombocytopenia.
Saito A; Yokohama A; Osaki Y; Ogawa Y; Nakahashi H; Toyama K; Mitsui T; Hashimoto Y; Koiso H; Uchiumi H; Saitoh T; Handa H; Sawamura M; Karasawa M; Murakami H; Tsukamoto N; Nojima Y
Eur J Haematol; 2012 Apr; 88(4):340-9. PubMed ID: 22221143
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.
Yang R; Han ZC
Int J Hematol; 2000 Jan; 71(1):18-24. PubMed ID: 10729989
[TBL] [Abstract][Full Text] [Related]
18. Novel approaches to refractory immune thrombocytopenic purpura.
Bussel JB
Blood Rev; 2002 Mar; 16(1):31-6. PubMed ID: 11913991
[TBL] [Abstract][Full Text] [Related]
19. The spleen dictates platelet destruction, anti-platelet antibody production, and lymphocyte distribution patterns in a murine model of immune thrombocytopenia.
Aslam R; Kapur R; Segel GB; Guo L; Zufferey A; Ni H; Semple JW
Exp Hematol; 2016 Oct; 44(10):924-930.e1. PubMed ID: 27417974
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of IVIG action in immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
Clin Lab; 2004; 50(3-4):133-40. PubMed ID: 15074465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
